Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Byannli (previously Paliperidone Janssen-Cilag International), paliperidone, Schizophrenia, Date of authorisation: 18/06/2020, Revision: 3, Status: Authorised
TO: